|
Title:
|
Prognostic Perfusion CT in Gynecological Cancer: A Randomized Phase III Trial of Every-3-Weeks Paclitaxel versus Dose Dense Weekly Paclitaxel in Combination with Carboplatin with or without Concurrent and Consolidation Bevacizumab in the Treatment of Primary Stage I, II, III, or IV Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer (Ancillary to GOG 0262)
|
|
More Information:
|